Fundraising FoxRA Capital — 2023 Investments
7 investments dated 2023 · listed companies and verified rows first · show all
Bia is a technology-driven electricity retailer in Colombia that lets businesses switch their energy provider and replace traditional meters with its proprietary BiaMonitor smart meter.
CleantechEnergyIoTBogota, CO
Sebastian Ruales(Founder)inGuillermo Plaza Roche(Director)Leonardo Velazquez Florez(Director)Juan Sebastian Ruales Duque(Director)Jaime E. Zunzunegui(Director)in
BoardNicolas Berman(Director)in
Co-investorsBBVA SPARKIDB LabKaszek VenturesMarathon VenturesNazcaNorte Ventures+4 more
Convergent Therapeutics develops radioantibody-based (PSMA-targeted) therapies for cancers, including metastatic castration-resistant prostate cancer (mCRPC).
BiotechHealthtechCambridge, US
Philip Kantoff(Chief Executive Officer, Co-Founder)inNeil Bander(Senior Scientific Advisor, Co-Founder)Alexander Brown(Executive Officer)inAndrew Davis(Chief Business and Strategy Officer)inElizabeth L. Montgomery(Chief People Officer)inEric M. Sullivan(Chief Financial Officer)in
Board seatJake Simson· per SEC Form D
Septerna is a biotechnology company that uses its proprietary Native Complex Platform to discover and develop oral small molecule therapies targeting GPCRs for endocrinology, immunology and inflammation, and metabolic diseases.
AI & Machine LearningBiotechDeep TechSouth San Francisco, US
Robert Lefkowitz(Founder)Arthur Christopoulos(Founder)Patrick Sexton(Founder)Ran Xiao(Executive Officer)inElizabeth Bhatt(Executive Officer)Samira Shaikhly(Executive Officer)in
Board seatJake Simson· per SEC Form D
Co-investorsCatalio Capital Management, LPSamsara BioCapitalVertex Ventures HCThird Rock Ventures
Convergent provides an AI simulation platform for enterprise training and skill development.
AI & Machine LearningEnterprise SoftwareHR TechSaaSLondon, GB
Co-investorsTechstarsAndreessen HorowitzOrbiMed
LENZ Therapeutics is a pharmaceutical company developing and commercializing VIZZ™, an FDA-approved aceclidine-based eye drop for treating presbyopia, a vision condition affecting over 128 million people in the US.
BiotechHealthtechMedical DevicesSan Diego, US
James McCollum(Co-founder, Board Member)Eef SchimmelpenninkinEvert Schimmelpennink(President and CEO)
Co-investorsAlpha Wave GlobalRaptor GroupRTW Investments L.P.Sectoral Asset ManagementVersant Ventures
Mariana Oncology, a Novartis company, develops precision radioligand therapies that deliver radioisotopes to diseased cells while limiting effects on healthy tissue.
BiotechHealthtechMedical Devices
Co-investorsAccess BiotechnologyAtlas VentureNextech InvestAccess IndustriesForbion
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.